Related Articles

Authors Name: N. Lalitha

TRIPS and Pharmaceutical Industry: Issues of Strategic Importance

Trade Related Intellectual Property Rights (TRIPS) brings in uniformity in the standards of intellectual property rights among the member countries of the WTO irrespective of their developmental statu...

On 28 Jan 2016

Government Intervention and Prices of Medicines: Lessons from Tamil Nadu

This paper looks at the approach adopted by the government of Tamil Nadu where drug procurement and supply is done through an autonomous agency. The paper emphasises the need for such goverment interv...

On 26 Jan 2016

A Status Paper on the Pharmaceutical Industry in France

This paper attempts to provide a comprehensive view of the status of the Pharmaceutical industry in France. As a background to the discussion, the paper first elaborates on the demographic features of...

On 26 Jan 2016

Protecting IPRs of Siddha Practitioners through People’s Biodiversity Register

Siddha system of medicine (SSM) focuses on addressing the root cause of the disease rather than treating the disease symptoms, and combinations of herbs, medicinal plants, animal and marine resources...

On 25 Jan 2016

Pesticide Applications in Bt Cotton Farms: Issues Relating to Environment and Non-Tariff Barriers

This paper is undertaken to examine various aspects of farm level adoption of Bt cotton in Gujarat as well as explore issues relating to environment and non-tariff barriers affecting the cotton trade...

On 27 Sep 2011

India’s Pharmaceutical Industry in the WTO Regime: A SWOT Analysis

A SWOT analysis of the Indian Pharmaceutical Industry (IPI) in the WTO regime reveals that the much acclaimed IPI’s expertise in process development skills were made possible by the amendments made...

On 28 Mar 2006